Results 41 to 50 of about 14,326,866 (362)

Patient-Reported Outcome Measures in Cancer Care

open access: yesJAMA Network Open
Key Points Question How does the integration of patient-reported outcome measures (PROMs) affect outcomes of cancer care? Findings In this update to a systematic review and meta-analysis of 45 randomized clinical trials examining the use of PROMs for ...
A. Balitsky   +11 more
semanticscholar   +1 more source

A qualitative process evaluation of electronic session-by-session outcome measurement in child and adolescent mental health services [PDF]

open access: yes, 2014
Background: Regular monitoring of patient progress is important to assess the clinical effectiveness of an intervention. Recently, initiatives within UK child and adolescent mental health services (CAMHS) have advocated the use of session-by-session ...
Marriott, Michael   +26 more
core   +1 more source

Outcomes after adrenalectomy for unilateral primary aldosteronism: an international consensus on outcome measures and analysis of remission rates in an international cohort

open access: yesThe Lancet Diabetes and Endocrinology, 2017
Summary Background Although unilateral primary aldosteronism is the most common surgically correctable cause of hypertension, no standard criteria exist to classify surgical outcomes.
T. Williams   +23 more
semanticscholar   +1 more source

Uses and Abuses of Patient Reported Outcome Measures (PROMs): Potential Iatrogenic Impact of PROMs Implementation and How It Can Be Mitigated [PDF]

open access: yes, 2013
Having been a national advocate for the use of patient reported outcome measures (PROMs) in Child and Adolescent Mental Health Services (CAMHS) in the UK for the last decade, I have become increasingly concerned that unless the potential iatrogenic ...
Wolpert, M, Miranda Wolpert
core   +1 more source

A core outcome set for clinical trials in acute diarrhoea.

open access: yes, 2015
OBJECTIVE:Core outcome sets are the baseline for what should be measured in clinical research and, thus, should serve as a guide for what should be collected and reported.
Vandenplas Y   +7 more
core   +1 more source

European Standard Clinical Practice Guideline and EXPeRT Recommendations for the Diagnosis and Management of Gastroenteropancreatic Neuroendocrine Neoplasms in Children and Adolescents

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Pediatric gastroenteropancreatic neuroendocrine neoplasms (GEP‐NENs) are extremely rare and clinically heterogeneous. Management has largely been extrapolated from adult practice. This European Standard Clinical Practice Guideline (ESCP), developed by the EXPeRT network in collaboration with adult NEN experts, provides (adult) evidence ...
Michaela Kuhlen   +23 more
wiley   +1 more source

Evaluating oral health promotion: need for quality outcome measures

open access: yes, 2006
Oral health promotion effectiveness reviews have identified the need to improve the quality of the evaluation of interventions. A project was undertaken to identify and assess the quality of available outcome measures.
Fuller, SS   +11 more
core   +1 more source

The utility of novel outcome measures in a naturalistic evaluation of schizophrenia treatment [PDF]

open access: yes, 2018
A number of naturalistic studies have investigated paliperidone palmitate using proxy measures of effectiveness. An unexplored option is to examine the utility of the mental health clustering tool, because it is used in UK clinical practice, measures ...
Donyai P   +8 more
core   +1 more source

Health‐Related Quality of Life and Symptom Severity Among Patients With PIK3CA‐Related Overgrowth Spectrum: A Mixed‐Methods Study to Understand Real‐World Experience With Alpelisib Treatment

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background PIK3CA‐related overgrowth spectrum (PROS) includes several rare overgrowth disorders resulting from somatic gain‐of‐function mutations in PIK3CA. Despite treatment advances, including the recent approval of alpelisib for PROS in the United States, literature detailing the patient experience with PROS is limited.
Vamsi Bollu   +8 more
wiley   +1 more source

Clinical and Biological Features of Response in Resistant Neuroblastoma to 131I‐Metaiodobenzylguanidine Radiotherapy in the Anti‐GD2 Immunotherapy Era

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background 131I‐metaiodobenzylguanidine (131I‐MIBG) radiotherapy is a key treatment for relapsed and refractory (R/R) neuroblastoma (NB). Patients with R/R disease treated in the modern era are increasingly exposed to anti‐GD2 immunotherapy, which exerts selective pressure and may modify both tumor cell state and microenvironment.
Benjamin J. Lerman   +7 more
wiley   +1 more source

Home - About - Disclaimer - Privacy